Evidence map›Paper›PMID 29222456›Full record

ArticleScientific reports2017

BMPs as new insulin sensitizers: enhanced glucose uptake in mature 3T3-L1 adipocytes via PPARγ and GLUT4 upregulation.

Isabelle Schreiber, Gina Dörpholz, Claus-Eric Ott, Bjørt Kragesteen, Nancy Schanze, Cory Thomas Lee, Josef Köhrle, Stefan Mundlos, Karen Ruschke, Petra Knaus

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Influence of BMP6 on Serotonin and Glucose Metabolism.International journal of molecular sciences · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Signaling pathways in obesity: mechanisms and therapeutic interventions.Signal transduction and targeted therapy · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Isabelle SchreiberInstitute of Chemistry and Biochemistry - Biochemistry, Berlin, Germany.
Gina DörpholzInstitute of Chemistry and Biochemistry - Biochemistry, Berlin, Germany.
Claus-Eric OttInstitute for Human Genetics and Medical Genetics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Bjørt KragesteenBerlin-Brandenburg School for Regenerative Therapies (BSRT), Berlin, Germany.
Nancy SchanzeInstitute for Experimental Endocrinology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Cory Thomas LeeInstitute of Chemistry and Biochemistry - Biochemistry, Berlin, Germany.
Josef KöhrleInstitute for Experimental Endocrinology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Stefan MundlosBerlin-Brandenburg School for Regenerative Therapies (BSRT), Berlin, Germany.
Karen RuschkeInstitute of Chemistry and Biochemistry - Biochemistry, Berlin, Germany.
Petra KnausInstitute of Chemistry and Biochemistry - Biochemistry, Berlin, Germany. knaus@chemie.fu-berlin.de.
Berlin-Brandenburger Centrum für Regenerative Therapien · DECharité - Universitätsmedizin Berlin · DEMax Planck Institute for Molecular Genetics · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin-resistance is the main cause of type 2 diabetes. Here we describe the identification and characterization of BMP2 and BMP6 as new insulin-sensitizing growth factors in mature adipocytes. We show that BMP2 and BMP6 lead to enhanced insulin-mediated glucose uptake in both insulin-sensitive and -insensitive adipocytes. We exclude a direct effect of BMP2 or BMP6 on translocation of GLUT4 to the plasma membrane and demonstrate that these BMPs increase GLUT4 protein levels equipotent to Rosiglitazone. BMPs induce expression of PPARγ as the crucial mediator for the insulin-sensitizing effect. A comprehensive RNA-Seq analysis in mature adipocytes revealed regulation of both BMP/Smad and PPARγ target genes. The effects of BMP2 and BMP6 are not completely redundant and include regulation of genes involved in glucose and fatty acid metabolism and adipokine expression. Collectively, these findings suggest the BMP2 and BMP6 pathway(s) as promising new drug targets to treat insulin resistance.

Indexed as

Insulin Resistance3T3-L1 CellsAnimalsBiological TransportBone Morphogenetic Protein 2GlucoseGlucose Transporter Type 4HumansMAP Kinase Signaling SystemMicePPAR gammaSignal TransductionUp-RegulationBMP2 protein, humanBone Morphogenetic Protein 2GlucoseGlucose Transporter Type 4PPAR gamma

Identifiers

PMID29222456
PMCPMC5722815
OpenAlexW2772736035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.